Cash & equivalents increased 134.3%
Cash & equivalents changed +134.3% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +134.3% from the comparable as-filed period.
Gross margin changed -639 basis points from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross profit changed -28.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Operating income changed -171.8% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Operating margin changed -26556 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Research & development changed +103.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed -14.0% from the comparable as-filed period.
Revenue changed -16.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.